Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy
المصدر:
Nasdaq GlobeNewswire
/
23 مايو 2018 05:30:45 America/Los_Angeles
N/A
شارك على،